Glycosylated protein expression in prokaryotes
AssigneeCornell Research Foundation, Inc.
InventorsMatthew Delisa, Cassandra Guarino, Thomas Mansell, Adam Fisher
Life of this patent
Estimating the term…
Loading patent…
AssigneeCornell Research Foundation, Inc.
InventorsMatthew Delisa, Cassandra Guarino, Thomas Mansell, Adam Fisher
Estimating the term…
The present invention relates to a prokaryotic host cell comprising eukaryotic glycosyltransferase activity, where the eukaryotic glycosyltransferase activity is eukaryotic dolichyl-linked UDP-GlcNAc transferase activity and eukaryotic mannosyl-transferase activity. Also disclosed is a method of producing a glycosylated protein by providing a prokaryotic host cell comprising the eukaryotic glycosyltransferase activity and culturing the prokaryotic host cell under conditions effective to produce a glycosylated protein. Another aspect of the present invention pertains to a method for screening bacteria or bacteriophages by expressing one or more glycans on the surface of a bacteria, attaching a label on the one or more glycans on the surface of the bacteria or on the surface of a bacteriophage derived from the bacteria, and analyzing the label in a high-throughput format. A glycosylated antibody comprising an Fv portion which recognizes and binds to a native antigen and an Fc portion which is glycosylated at a conserved asparagine residue is also disclosed.
A prokaryotic host cell comprising eukaryotic glycosyltransferase activity, wherein the eukaryotic glycosyltransferase activity is eukaryotic dolichyl-linked UDP-GlcNAc transferase activity and eukaryotic mannosyltransferase activity.
A glycoprotein conjugate comprising a protein and at least one peptide comprising a D-X1-N-X2-T motif fused to the protein, wherein D is aspartic acid, X1 and X2 are any amino acid other than proline, N is asparagine, and T is threonine.
A method of producing a glycosylated protein, said method comprising:
A method for screening bacteria or bacteriophages, said method comprising:
A glycosylated antibody comprising:
The glycosylated antibody of claim 39, wherein the antibody is monoclonal.
The glycosylated antibody of claim 39, wherein the antibody is polyclonal.
Dependencies are inferred from the claim text.